Chairman of the Board – Peer Nørkjær

Peer Nørkjær holds a M.Sc. Pharmacy from the Copenhagen University (1978) and in addition, a M.Sc. Sales and Marketing from the Copenhagen Business School (1983). 

Career overview:

Peer started his career in ICI-Pharma Denmark (later on part of Zenica) and has had several managerial positions within different internationally renowned pharmaceutical companies, including Marketing Director Ciba-Geigy Denmark, CEO for Johnson&Johnson / Janssen-Cilag in Israel. In 1999 Peer was appointed Managing Director of Janssen-Cilag Switzerland and in 2004 he was appointed Managing Director of Janssen-Cilag Denmark. In 2007, the new chairman of the B&O Medicom board was awarded a license from the Danish ministry to become a Managing Pharmacist at Tårnby Pharmacy near Copenhagen, Denmark. 

Other positions:

Peer has been in the LIF (LIF=Danish Association of the Pharmaceutical Industry) board of directors from 1992-1996. In 1999 he was appointed Chairman of Pharma Israel and in 2006 he rejoined LIF board of directors. In 2007 he was appointed Chairman of Board for B&O Medicom.

Member of the board – Alejandra Mørk

Alejandra Mørk holds a Ph.D. from the Royal Danish School of Pharmacy in Copenhagen (1994) and a Master of Science in Pharmacy (1985) also from the Royal Danish School of Pharmacy, Copenhagen.

Career overview:

Alejandra began her career with DAK-Laboratoriet/Nycomed in Denmark and for the past 18 years she has held a variety of positions within Nycomed in Clincal Development, Regulatory Affairs and Project Management, including Clinical Co-Ordinator (1990-1991), Head of Medical Department (1992-1994), Vice President (VP) Project Management International Product Development (1993), Director Regulatory Affairs (1994-1997), Project Management, Strategic Portfolio Management and VP International Marketing for Consumer Health Products (1997-1998) and VP Portfolio Development (1999 -2003). In 2003, Alejandra was promoted to Senior Vice President, International Product Development at Nycomed. In January 2008, Alejandra became CEO and owner of KLIFO A/S, a Danish contract research organisation (CRO) specialised in clinical research and development of pharmaceuticals, biotech products and medical devices. She was appointed to the board of directors of Bang & Olufsen Medicom in 2007.

Other positions:

Member of the Board of the Pharmaceutical Society of Denmark

Member of the Board of the limited partnership K/S Eskilstuna

Member of the advisory board for Innovationsalliancer, Tuborg Foundation and Nyx

Member of Committee on Communication Policy Committee, LIF (LIF = Danish Association of the Pharmaceutical Industry)

Member of ‘Akademiet for Tekniske Videnskaber’

Member of the board – Peter Thostrup

Peter Thostrup holds a Masters in Economics from the Aarhus University (1987) and a Masters of Business Administration from the Tuch School at Dartmouth College, New Hampshire, USA (1986).

Career Overview:

Peter started his career in the financial sector in Privatbanken (The Private Bank) Denmark and Unibank plc, London, UK. In 1993, Peter began his 14 year career with Bang & Olufsen as the Head of Finance. In 1995 he was promoted to Director of Finance and in 1996, he became the Executive Vice President of Bang & Olufsen and has held this position for the past 11 years. Peter has served as a member of the Executive Board of B&O Medicom for several years and in 2007 he was re-instated to the new board of Directors of Bang & Olufsen Medicom and represents the Bang & Olufsen share of the company.

Other positions/Honorary offices:

Board member of Nordic Bioscience A/S